Assessment of isomalt for colon-specific delivery and its comparison with lactulose

AAPS PharmSciTech

Volumn 14, Issue 1, 2013, Pages 53-59

  Dehghan, Mohamed Hassan G ^a   Gupta, V Rama Mohan ^b   Asif, Shaikh Mohammed ^a,c   Darwis, Yusrida ^d   Rizwan, Mohammad ^c,e   Mundada, Veenu Piyush ^f  

^a Y B CHAVAN COLLEGE OF PHARMACY   (India)

^b Pulla Reddy Institute of Pharmacy   (India)

^c WOCKHARDT LIMITED   (India)

^d SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^e HAMDARD UNIVERSITY   (India)

^f DR REDDY'S LABORATORIES LTD   (India)

Author keywords

5 amino salicylic acid; CODESTM system; colon specific delivery system; isomalt; Maillard reaction

Indexed keywords

ACETYLSALICYLIC ACID; ISOMALT; LACTULOSE;

ANIMAL EXPERIMENT; ARTICLE; COLON FLORA; CONTROLLED STUDY; DEGRADATION; DRUG DELIVERY SYSTEM; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; COLON; DISACCHARIDES; LACTULOSE; MAILLARD REACTION; MALE; MESALAMINE; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY; SUGAR ALCOHOLS;

EID: 84878558425     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-012-9886-0     Document Type: Article

References (28)

1. Yang L, Chu JS, Fix JA. Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. Int J Pharm. 2002;235:1-15.
2. Pinto JF. Site-specific drug delivery systems within the gastro-intestinal tract: from the mouth to the colon. Int J Pharm. 2010;395:44-52.
3. McConnell EL, Liu F, Basit AW. Colonic treatments and targets: issues and opportunities. J Drug Target. 2009;17:335-63.
4. Basit AW. Advances in colonic drug delivery. Drugs. 2005;65:1991-2007.
5. Jain A, Gupta Y, Jain SK. Perspectives of biodegradable natural polysaccharides for site-specific drug delivery to the colon. J Pharm Pharm Sci. 2007;10:86-128.
6. Sinha VR, Kumria R. Polysaccharides in colon-specific drug delivery. Int J Pharm. 2001;224:19-38.
7. Aurora J, Talwar N, Pathak V. Colonic drug delivery challenges and opportunities - an overview. Eur Gastroenterol Rev. 2006;1:1-4.
8. Katsuma M, Watanabe S, Kawai H, Takemura S, Masuda Y, Fukui M. Studies on lactulose formulations for colon-specific drug delivery. Int J Pharm. 2002;249:33-43.
9. Katsuma M, Watanabe S, Takemura S, Sako K, Sawada T, Masuda Y, et al. Scintigraphic evaluation of a novel colon-targeted delivery system (CODES™) in healthy volunteers. J Pharm Sci. 2004;93:1287-99.
10. Katsuma M, Watanabe S, Kawai H, Takemura S, Sako K. Effects of absorption promoters on insulin absorption through colon-targeted delivery. Int J Pharm. 2006;307:156-62.
11. Li J, Yang L, Ferguson S, Hudson T, Watanabe S, Katsuma M, et al. In vitro evaluation of dissolution behavior for a colon-specific drug delivery system (CODES™) in multi-pH media using United States Pharmacopeia apparatus II and III. AAPS PharmSciTech. 2002;3:59-67.
12. Watanabe S, Kawai H, Katsuma M, Fukui M. Colon-specific drug release system. US Patent 2003; 6368629.
13. Yang L, Watanabe S, Li J, Chu JS, Katsuma M, Yokohama S, et al. Effect of colonic lactulose availability on the timing of drug release onset in vivo from a unique colon-specific drug delivery system (CODES™). Pharm Res. 2003;20:429-34.
14. Brands CMJ, Alink GM, Van-Boekel MAJS, Jongen WMF. Mutagenicity of heated sugar-casein systems: effect of the Maillard reaction. J Agric Food Chem. 2000;48:2271-5.
15. Dedhiya MG, Rastogi SK, Chhettry A, Mani N, Periclou A, Rao N. Modified and immediate release formulations of memantine. US Patent App 2006; 20070065512.
16. Ndindayino F, Henrist D, Kiekens F, Vervaet C, Remon JP. Characterization and evaluation of isomalt performance in direct compression. Int J Pharm. 1999;189:113-24.
17. Grupp U, Siebert G. Metabolism of hydrogenated palatinose, an equimolar mixture of α-D-glucopyranosido-1,6-sorbitol and α-D-glucopyranosido- 1,6-mannitol. Res Exp Med (Berlin). 1978;173:261-78.
18. Hanauer SB. Aminosalicylates in inflammatory bowel disease. Aliment Pharmacol Ther. 2004;20:60-5.
19. Friend DR. New oral delivery systems for treatment of inflammatory bowel disease. Adv Drug Deliv Rev. 2005;57:247-65.
20. Klotz U, Schwab M. Topical delivery of therapeutic agents in the treatment of inflammatory bowel disease. Adv Drug Deliv Rev. 2005;57:267-79.
21. Lee EJD, Ang SB. Simple and sensitive high performance liquid chromatographic assay for 5-aminosalicylic acid and acetyl-5-aminosalicylic acid in serum. J Chromatogr B Biomed Sci Appl. 1987;413:300-4.
22. Nelson DL, Cox MM. Lehninger principles of biochemistry. 5th ed. New York: W.H. Freeman and Company; 2009.
23. Garrett RH, Grisham CM. Biochemistry. 4th ed. Massachusetts: Cengage Learning; 2008.
24. Lee A, Zumbe A, Storey D. Breath hydrogen after ingestion of the bulk sweeteners sorbitol, isomalt and sucrose in chocolate. Br J Nutr. 1994;71:731-7.
25. Storey D, Lee D, Bornet F, Brouns F. Gastrointestinal tolerance of erythritol and xylitol ingested in a liquid. Eur J Clin Nutr. 2007;61:349-54.
26. Van-Weerden EJ, Huisman J. The digestion process of the sugar alcohol isomalt in the intestinal tract of the pig. Br J Nutr. 1993;69:455-66.
27. Waugh A, Grant A. Ross and Wilson anatomy and physiology in health and illness. 9th ed. Edinburgh: Churchill Livingstone; 2004.
28. Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev. 2001;81:1031-64.